VanEck Biotech ETFBBH
BBH
0
Funds holding %
of 7,407 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
3% less capital invested
Capital invested by funds: $151M [Q3] → $147M (-$4.04M) [Q4]
2% less funds holding
Funds holding: 113 [Q3] → 111 (-2) [Q4]
23% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 31
41.18% less ownership
Funds ownership: 78.3% [Q3] → 37.12% (-41.18%) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for BBH.
Financial journalist opinion
Neutral
Seeking Alpha
1 month ago
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Neutral
Zacks Investment Research
1 month ago
Should You Invest in the VanEck Biotech ETF (BBH)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011.
Neutral
Zacks Investment Research
3 months ago
Should You Invest in the VanEck Biotech ETF (BBH)?
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
Neutral
Business Wire
3 months ago
VanEck Announces Year-End Distributions for VanEck Equity ETFs
NEW YORK--(BUSINESS WIRE)--VanEck has announced the 2024 annual distributions per share for its VanEck equity exchange-traded funds (ETFs).
Neutral
Zacks Investment Research
5 months ago
Should You Invest in the VanEck Biotech ETF (BBH)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011.
Neutral
Zacks Investment Research
8 months ago
Should You Invest in the VanEck Biotech ETF (BBH)?
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
Positive
Seeking Alpha
8 months ago
BBH: Buy Rating, As Tech Investors Look Beyond FAANG
Biotechnology sector experiencing exponential growth driven by emerging technologies addressing global challenges. VanEck Biotech ETF tracks top U.S.-listed biotech companies, offers exposure to innovative therapies and technologies. BBH is under-discovered compared to peers, offers potential for trend change in favor of biotech sector.
Positive
InvestorPlace
9 months ago
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for June 2024
I'm on the hunt for ‘Strong Buy' biotech stocks. According to Finviz.com, there are 680 U.S.-listed biotech stocks.
Positive
Zacks Investment Research
9 months ago
Biotech ETF (BBH) Hits New 52-Week High
VanEck Biotech ETF BBH is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and moved up 21.4% from its 52-week low price of $142.51/share.
Neutral
Zacks Investment Research
10 months ago
Should You Invest in the VanEck Biotech ETF (BBH)?
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
Charts implemented using Lightweight Charts™